ENB Therapeutics Closes Series A Round of Funding

By WebmasterSeptember 20, 2018November 1st, 2024No Comments

ENB Therapeutics Closes Series A Round of Funding
Remiges led the Series A round of Financing

Previous PostCorbus Pharmaceuticals Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from Jenrin Discovery; Includes CRB-4001 with Planned NIH-Supported Phase 2 Study
Next PostDigital health startup Keriton names new CEO to scale operations